Somatostatin-analogue treatment is safe, effective and improves quality of life of patients suffering neuroendocrine tumours. Results from a national multicenter observational stu…

Aims: Neuroendocrine tumors (NET) are rare malignancies. There are few data available regarding patients suffering NET in Hungary. There are limited experiences in the majority of hospitals because of the small number of pts. Therefore a multicenter observational study was performed in 2004 in Hungary in a large-number patient population. The objective of the study was to assess the safety, the efficacy, and the effect on patients' quality of life receiving long-term somatostatin-analogue treatment (Sandostatin-LAR® – SST-LAR). Patients: histologically proven NET pts. Inclusion criteria: symptomatically effectiv…